Physician profile
Jency Thomas
NPI 1861833808
$2,255.06
in general payments reported to CMS, 2019-2025
19 companies · $486 in 2025
The $486 reported for 2025 was more than what 75% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.62 · 2022: $616 · 2023: $539 · 2024: $558 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,583.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $689.37 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $379.84 | 2021-2025 | Ubrelvy, Vraylar |
| Amgen INC. | $277.28 | 2022-2024 | Prolia, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.65 | 2022-2024 | Ofev |
| Astrazeneca Pharmaceuticals Lp | $121.22 | 2022-2024 | Airsupra, Farxiga |
| Amneal Pharmaceuticals LLC | $102.27 | 2022-2025 | Unithroid |
| Novartis Pharmaceuticals Corporation | $99.72 | 2022-2025 | |
| Edwards Lifesciences Corporation | $96.47 | 2025 | Sapien 3 Ultra Resilia |
| Glaxosmithkline, LLC. | $91.93 | 2023-2024 | Shingrix, Arexvy |
| Abbott Laboratories | $61.83 | 2022-2025 | Freestyle Libre 3 |
| Pfizer INC. | $41.13 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $28.13 | 2022-2023 | Eliquis |
| Mylan Specialty L.P. | $26.03 | 2022 | |
| Astellas Pharma US INC | $23.60 | 2025 | Veozah |
| Exact Sciences Corporation | $20.98 | 2023 | Cologuard Collection Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $20.75 | 2024 | Nexletol |
| Merck Sharp & Dohme LLC | $19.68 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Janssen Pharmaceuticals, INC | $16.81 | 2022 | |
| Lilly USA, LLC | $15.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jency Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.